7.37 USD
↗ 0.00 (0.01%)PRE MARKET (AS OF 09:02 AM EST)
Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $7.37. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place AVTX at a fair price relative to peers.
Technical & fundamental data as of Nov 16, 2026.